| Structure | Chemical Name | CAS | MF |
|
2,5-Piperazinedione,1-(2-methyl-1-oxopropyl)-(9CI)
|
151079-68-4
|
C8H12N2O3
|
|
2-Propanone,1-[3-(phenylmethyl)-2(3H)-benzothiazolylidene]-(9CI)
|
151080-24-9
|
C17H15NOS
|
|
2-Propanone,1-(3-cyclopentyl-2(3H)-benzothiazolylidene)-(9CI)
|
151080-25-0
|
C15H17NOS
|
|
dimeric hemoglobin, Scapharca inaequivalvis
|
151087-63-7
|
|
|
2(1H)-Pyrimidinone, 4-amino-5-(1-propynyl)- (9CI)
|
151091-68-8
|
C7H7N3O
|
|
1,2,4-Triazin-6(1H)-one, 2,5-dihydro-3-(1,2,3,6-tetrahydro-1-(2-hydrox y-2-(4-nitrophenyl)ethyl)-4-pyridinyl)-, hydrochloride
|
151092-59-0
|
|
|
Benzoyl bromide, 2-methoxy- (9CI)
|
151093-32-2
|
C8H7BrO2
|
|
Benzoyl bromide, 2-hydroxy- (9CI)
|
151093-36-6
|
C7H5BrO2
|
|
Benzoyl bromide, 3-hydroxy- (9CI)
|
151093-37-7
|
C7H5BrO2
|
|
Benzoyl bromide, 4-hydroxy- (9CI)
|
151093-38-8
|
C7H5BrO2
|
|
Benzoylbromide,4-amino-(9CI)
|
151093-40-2
|
C7H6BrNO
|
|
Benzoyl bromide, 4-fluoro- (9CI)
|
151093-41-3
|
C7H4BrFO
|
|
Benzoyl bromide, 4-cyano- (9CI)
|
151093-43-5
|
C8H4BrNO
|
|
4,5-DIHYDRO-2-(3-IODOPHENYL)-4,4-DIMETHYLOXAZOLE
|
151094-71-2
|
C11H12INO
|
|
(2S)-2-(2,4-dioxo-1H-quinazolin-3-yl)-3-phenyl-propanoic acid
|
151094-81-4
|
C17H14N2O4
|
|
Ethanone, 1-(5-ethoxy-4-nitro-2-thienyl)- (9CI)
|
151094-98-3
|
C8H9NO4S
|
|
6-ACETYL-2,3-DIHYDRO-1H-THIENO[2,3-B][1,4]THIAZIN-2-ONE
|
151095-12-4
|
C8H7NO2S2
|
|
Moxifloxacin
|
151096-09-2
|
C21H24FN3O4
|
|
2-BROMO-3,4,5,6-TETRAFLUOROBENZOYL CHLORIDE
|
151096-42-3
|
C7BrClF4O
|
|
1-cyclopropyl-6,8-difluoro-4-oxo-7-((4aR,7aR)-tetrahydro-1H-pyrrolo[3,4-b]pyridin-6(2H,7H,7aH)-yl)-1,4-dihydroquinoline-3-carboxylic acid
|
151096-44-5
|
C20H21F2N3O3
|
|
4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
|
151096-96-7
|
C15H20N2O2
|
|
4-benzyl-1-oxa-4,9-diazaspiro[5.5]undecane
|
151096-97-8
|
C15H22N2O
|
|
1,4,9-Triazaspiro[5.5]undecane,1,4-dimethyl-(9CI)
|
151097-18-6
|
C10H21N3
|
|
3-(aminomethyl)-1-benzhydrylazetidin-3-ol
|
151097-26-6
|
C17H20N2O
|
|
ethyl 5-(pyridin-4-yl)-1,2,4-oxadiazole-3-
carboxylate
|
151097-45-9
|
C10H9N3O3
|
|
ethyl 5-(4-methoxyphenyl)-1,2,4-oxadiazole-3-carboxylate
|
151098-14-5
|
C12H12N2O4
|
|
Ethyl 5-pyridin-3-yl-1,2,4-oxadiazole-3-carboxylate
|
151098-17-8
|
C10H9N3O3
|
|
3-(ethoxycarbonyl)-5-(4'-fluorophenyl)-1,2,4-oxadiazole
|
151098-20-3
|
C11H9FN2O3
|
|
1,8-Naphthyridin-4-ol,6-ethoxy-7-methyl-(9CI)
|
151099-09-1
|
C11H12N2O2
|
|
1,8-Naphthyridin-4-ol,6-ethoxy-2,7-dimethyl-(9CI)
|
151099-27-3
|
C12H14N2O2
|
|
1,8-Naphthyridin-4-ol,6-ethoxy-3,7-dimethyl-(9CI)
|
151099-29-5
|
C12H14N2O2
|
|
Propanenitrile, 2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]- (9CI)
|
151101-94-9
|
C9H11N3O3
|
|
1,2,4-TRIAZOLO[4,3-A]PYRIDINE, 3-(TRIFLUOROMETHYL)-
|
151102-13-5
|
C7H4F3N3
|
|
4-Difluoromethoxy-3-hydroxybenzaldehyde
|
151103-08-1
|
C8H6F2O3
|
|
4-(DIFLUOROMETHOXY)-3-(CYCLOPROPYLMETHOXY)-BENZALDEHYDE
|
151103-09-2
|
C12H12F2O3
|
|
Pyridine, 4-ethyl-, radical ion(1+) (9CI)
|
151103-55-8
|
C7H9N
|
|
Pyridine, 3-ethyl-, radical ion(1+) (9CI)
|
151103-56-9
|
C7H9N
|
|
2-CHLORO-5-(PYRROLIDIN-1-YLSULFONYL)BENZOIC ACID
|
151104-21-1
|
C11H12ClNO4S
|
|
2-METHYL-5-(METHYLSULFONYL)BENZOIC ACID
|
151104-37-9
|
C9H10O4S
|
|
3-(chlorosulfonyl)-4,5-diMethylbenzoic acid
|
151104-64-2
|
C9H9ClO4S
|
|
3,4-dichloro-5-(chlorosulfonyl)-benzoic acid
|
151104-67-5
|
C7H3Cl3O4S
|
|
3-AMino-5-(Methylsulfonyl)benzoic acid
|
151104-75-5
|
C8H9NO4S
|
|
7-(3-bromo-4,5-bis(4-fluorophenyl)-2-(1-methylethyl)-1H-pyrrol-1-yl)-3,5-dihydroxy-6-heptenoic acid methyl ester
|
151106-12-6
|
C27H28BrF2NO4
|
|
3-methyl-6,7-methylenedioxy-1,2,3,4-tetrahydroisquinoline
|
151109-51-2
|
C11H13NO2
|
|
tetraaquacalcium perbromate
|
151109-52-3
|
Br2CaH8O12
|
|
4,5-Didehydro BriMonidine
|
151110-15-5
|
C11H8BrN5
|
|
DICHLORO(2 2':6' 2''-TERPYRIDINE)-
|
151120-25-1
|
C15H11N3.Cl2Pt.2H2O
|
|
8-(6-Hydroperoxy-3,7-diMethyl-2,7-octadienyloxy)psoralen
|
151121-39-0
|
C21H22O6
|
|
Progesterone 20-Hydroxy IMpurity
|
151122-70-2
|
C22H32O3
|
|
(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydrox y-2-(tetracosanoylamino)octadec-4-enoxy]-4-sulfooxy-oxane
|
151122-71-3
|
C48H93NO11S
|
|
leucettamine A
|
151124-32-2
|
C30H52N2O2
|
|
Pramlintide
|
151126-32-8
|
C171H267N51O53S2.C2H4O2.H2O
|
|
|
almagcit
|
151126-69-1
|
|
|
5-[(2R)-2-([(2R)-2-(3-CHLOROPHENYL)-2-HYDROXYETHYL]AMINO)PROPYL]-1,3-BENZODIOXOLE-2,2-DICARBOXYLATE DISODIUM
|
151126-84-0
|
C20H18ClNNa2O7
|
|
|
Disperse orange 149
|
151126-94-2
|
|
|
|
Lite Line
|
151127-50-3
|
|
|
5,9:7,10a-Dimethano-10aH-cyclononoxazol-2(3H)-one,octahydro-,(S)-(9CI)
|
151131-78-1
|
C12H17NO2
|
|
2,4-Azetidinedicarboxylicacid,1-methyl-,(2S-trans)-(9CI)
|
151131-84-9
|
C6H9NO4
|
|
(2S)-4-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-[[(phenylmethoxy)carbonyl]amino]butanoic acid
|
151132-82-0
|
C27H26N2O6
|
|
NEBULARINE CEP
|
151132-95-5
|
C46H61N6O7PSi
|
|
5-fluoro-2-thio-2'-deoxyuridylate
|
151134-50-8
|
C9H12FN2O7PS
|
|
NIR-667 N-SUCCINIMIDYL ESTER
|
151134-79-1
|
C30H35N4O5.Cl
|
|
4'-Hydroxy-2,4-dimethoxychalcone
|
151135-64-7
|
C17H16O4
|
|
Kanzonol C
|
151135-82-9
|
C25H28O4
|
|
1-(3-(3-methyl-2-butenyl)-2,4-(dihydroxy)phenyl)-3-(2,2-dimethyl-8-hydroxy-2H-benzopyran-6-yl)-2-propen-1-one
|
151135-83-0
|
C25H26O5
|
|
TRIS(2,2,6,6-TETRAMETHYL-3,5-HEPTANE-DIONATO)LANTHANUM TETRAGLYME ADDUCT
|
151139-14-9
|
C43H79LaO11
|
|
N-α-Fmoc-N-im-trityl-L-histidine N-carboxyanhydride
|
151139-74-1
|
C41H31N3O5
|
|
4-DIMETHYL-L-GLUTAMIC ACID
|
151139-88-7
|
C7H13NO4
|
|
macrostemonoside E
|
151140-39-5
|
C57H94O28
|
|
swertiapunimarin
|
151140-40-8
|
C22H32O14
|
|
(4-AMINO-3-IODOPHENYL)-N-METHYLMETHANESULFONAMIDE
|
151140-66-8
|
C8H11IN2O2S
|
|
1-[3-[3-[4-(5-methoxypyrimidin-4-yl)piperazin-1-yl]propyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide
|
151140-96-4
|
C22H30N6O3S
|
|
1-Azatetracyclo[2.2.0.02,6.03,5]hexane,4-nitro-(9CI)
|
151141-40-1
|
C5H4N2O2
|
|
1-Azatetracyclo[2.2.0.02,6.03,5]hexane,2-nitro-(9CI)
|
151141-41-2
|
C5H4N2O2
|
|
1,2-Bipiperazine(9CI)
|
151142-74-4
|
C8H18N4
|
|
glycyl-histidyl-omega(NHCO)lysine, monoacetate
|
151142-89-1
|
C16H28N6O6
|
|
L-2-AMINO-4-BROMO-4-PENTENOIC ACID
|
151144-96-6
|
C5H8BrNO2
|
|
H-HIS-LYS-OH HBR
|
151151-29-0
|
C12H22BrN5O3
|
|
BETA-AMYLOID (32-35)
|
151151-30-3
|
C19H36N4O5S
|
|
2'-DEOXYADENOSINE 5'-MONOPHOSPHATE SODIUM SALT
|
151151-31-4
|
C10H12N5Na2O6P
|
|
2'-Deoxycytidine-5'-diphosphate trisodium salt
|
151151-32-5
|
C9H18N3NaO11P2
|
|
1,3-Benzenedicarboxylic acid, 5,5-(2,5-dimethyl-1,4-piperazinediyl)bis(1,6-dihydro-6-oxo-1,3,5-triazine-4,2-diyl)imino(8-hydroxy-3,6-disulfo-1,7-naphthalenediyl)azobis-, ammonium salt
|
151151-34-7
|
|
|
1,3-Benzenedicarboxylic acid, 5,5-6-(4-morpholinyl)-1,3,5-triazine-2,4-diylbis(imino-4,1-phenyleneazo)bis-, ammonium salt
|
151151-38-1
|
C35H31N11O9
|
|
2-Naphthalenecarboxylicacid,2,7-diamino-1,2,3,4-tetrahydro-(9CI)
|
151153-06-9
|
C11H14N2O2
|
|
Cyclopropanecarbonyl chloride, 1-(2-chlorophenyl)- (9CI)
|
151154-92-6
|
C10H8Cl2O
|
|
2,3-DIHYDROBENZO[B]FURAN-7-METHANOL
|
151155-53-2
|
C9H10O2
|
|
Cyclobutanecarbonyl chloride, 1-(4-fluorophenyl)- (9CI)
|
151157-29-8
|
C11H10ClFO
|
|
Cyclobutanecarbonyl chloride, 1-(2-fluorophenyl)- (9CI)
|
151157-31-2
|
C11H10ClFO
|
|
1-(2-BROMOPHENYL)CYCLOBUTANECARBOXYLIC ACID
|
151157-44-7
|
C11H11BrO2
|
|
1-(2-CHLOROPHENYL)CYCLOBUTANECARBOXYLIC ACID
|
151157-45-8
|
C11H11ClO2
|
|
1-(4-FLUOROPHENYL)CYCLOBUTANECARBOXYLIC ACID
|
151157-46-9
|
C11H11FO2
|
|
1-(2-methylphenyl)cyclobutane-1-carboxylic acid
|
151157-47-0
|
C12H14O2
|
|
1-(2-fluorophenyl)cyclobutanecarboxylic acid
|
151157-48-1
|
C11H11FO2
|
|
1-(4-BROMOPHENYL)CYCLOBUTANECARBOXYLIC ACID
|
151157-49-2
|
C11H11BrO2
|
|
1-(2,4-dichlorophenyl)cyclobutane-1-carboxylic acid
|
151157-50-5
|
C11H10Cl2O2
|
|
1-(2-Trifluoromethylphenyl)cyclobutanecarboxylic acid
|
151157-52-7
|
C12H11F3O2
|
|
1-(3-CHLOROPHENYL)CYCLOBUTANECARBOXYLIC ACID
|
151157-55-0
|
C11H11ClO2
|
|
1-[3-(trifluoromethyl)phenyl]cyclobutane-1-carboxylic acid
|
151157-58-3
|
C12H11F3O2
|
|
MIDAXIFYLLINE
|
151159-23-8
|
C16H25N5O2
|
|
TFA-cLeu
|
151159-24-9
|
C8H10F3NO3
|